


Healthcare News Roundup: Neuro
HSMN NewsFeed - 10 May 2017
Bioness and Ottobock Announce Strategic European Distribution Partnership
Bioness and Ottobock Announce Strategic European Distribution Partnership
HSMN NewsFeed - 8 May 2017
SI-BONE, Inc. Announces U.S. Military's TRICARE Now Covers MIS SI Joint Fusion
SI-BONE, Inc. Announces U.S. Military's TRICARE Now Covers MIS SI Joint Fusion
HSMN NewsFeed - 27 Apr 2017
Moberg Receives $3 Million to Expand Its Focus on Precision Management of Brain Injured Patients
Moberg Receives $3 Million to Expand Its Focus on Precision Management of Brain Injured Patients
HSMN NewsFeed - 20 Apr 2017
Arkis BioSciences Expands Clinical Use Of Its New Minimally Invasive Tunneling Guidewire(TM) Technology
Arkis BioSciences Expands Clinical Use Of Its New Minimally Invasive Tunneling Guidewire(TM) Technology
HSMN NewsFeed - 13 Apr 2017
Zyga Releases 24-month CT Fusion and Clinical Results for SImmetry SI Joint Fusion with Decortication
Zyga Releases 24-month CT Fusion and Clinical Results for SImmetry SI Joint Fusion with Decortication
HSMN NewsFeed - 11 Apr 2017
Valeo Pharma and Zambon form partnership for Parkinson's Disease Treatment Xadago(R) (safinamide) in Canada
Valeo Pharma and Zambon form partnership for Parkinson's Disease Treatment Xadago(R) (safinamide) in Canada
HSMN NewsFeed - 7 Apr 2017
Medtronic Announces Voluntary Worldwide Recall of its StrataMR(TM) Adjustable Valves and Shunts
Medtronic Announces Voluntary Worldwide Recall of its StrataMR(TM) Adjustable Valves and Shunts
HSMN NewsFeed - 6 Apr 2017
Amarantus Provides Update on Restructuring Efforts and Letter of Intent with SeD Biomedical, Inc.
Amarantus Provides Update on Restructuring Efforts and Letter of Intent with SeD Biomedical, Inc.
HSMN NewsFeed - 27 Mar 2017
Dinutuximab beta receives positive recommendation for the treatment of high-risk neuroblastoma in Europe
Dinutuximab beta receives positive recommendation for the treatment of high-risk neuroblastoma in Europe
